Skip to main content

Part 2: Excipient Considerations in the Development and Approval of Animal Drug Products

Presentation Icon
This was a joint webinar organized between IPEC-Americas and Generic Animal Drug Alliance (GADA).

During this two-part webinar, presenters representing GADA, IPEC-Americas and FDA - CVM (Center for Veterinary Medicine) provided an introduction to the regulatory process for animal drug development and approval, manufacturing, and regulatory policies, practices and ingredient requirements. CVM discussed considerations for excipients used in the animal drug industry, with a specific focus on generic animal drug products.

You can access this item by buying entire course

Buy entire course: